Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

227.06
-1.3300-0.58%
Post-market: 227.060.00000.00%19:34 EDT
Volume:927.43K
Turnover:211.11M
Market Cap:25.06B
PE:24.11
High:229.80
Open:228.51
Low:226.81
Close:228.39
52wk High:248.84
52wk Low:171.18
Shares:110.37M
Float Shares:110.00M
Volume Ratio:0.77
T/O Rate:0.84%
Dividend:3.32
Dividend Rate:1.46%
EPS(TTM):9.42
EPS(LYR):8.75
ROE:14.60%
ROA:6.40%
PB:3.33
PE(LYR):25.95

Loading ...

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 16

Leerink Partners Adjusts Quest Diagnostics Price Target to $244 From $240, Maintains Outperform Rating

MT Newswires Live
·
Jul 16

Quest Diagnostics Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since June 2024

Dow Jones
·
Jul 15

Biovica Receives Ninth Work Order from Customer

Reuters
·
Jul 14

Quest Diagnostics is Maintained at Neutral by Baird

Dow Jones
·
Jul 13

Quest Diagnostics price target raised to $236 from $232 at Baird

TIPRANKS
·
Jul 13

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Quest Diagnostics (DGX) and Gilead Sciences (GILD)

TIPRANKS
·
Jul 13

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Quest Diagnostics Expands Oncology Testing Access Via Flatiron Health's OncoEMR MPI

MT Newswires Live
·
Jul 08

Quest Diagnostics Integrates Oncology Testing into Flatiron Oncoemr Via Pilot with American Oncology Network

Reuters
·
Jul 08

Quest Diagnostics Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 07

Quest Diagnostics (DGX) Could Be 4% Undervalued On Haystack MRD Approval

Simply Wall St.
·
Jul 06

How Investors Are Reacting To Quest Diagnostics (DGX) New MRD Test Milestone And Attunio Partnership

Simply Wall St.
·
Jul 04

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 02

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 30

Quest Diagnostics Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 26

Quest Diagnostics’ Haystack MRD test receives New York SDOH approval

TIPRANKS
·
Jun 24

Quest Diagnostics Receives New York State Approval for Haystack Mrd®, Broadening Patient Access to Ctdna Minimal Residual Disease Testing

THOMSON REUTERS
·
Jun 24

Quest Wins New York State Approval for Haystack MRD Ctdna Test

Reuters
·
Jun 24

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 24